GB0320300D0 - Pyrimidothiophene compounds - Google Patents

Pyrimidothiophene compounds

Info

Publication number
GB0320300D0
GB0320300D0 GB0320300A GB0320300A GB0320300D0 GB 0320300 D0 GB0320300 D0 GB 0320300D0 GB 0320300 A GB0320300 A GB 0320300A GB 0320300 A GB0320300 A GB 0320300A GB 0320300 D0 GB0320300 D0 GB 0320300D0
Authority
GB
United Kingdom
Prior art keywords
pyrimidothiophene
compounds
pyrimidothiophene compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0320300A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Vernalis Cambridge Ltd
Cancer Research Technology Ltd
Original Assignee
Institute of Cancer Research
Cancer Research Technology Ltd
Ribotargets Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research, Cancer Research Technology Ltd, Ribotargets Ltd filed Critical Institute of Cancer Research
Priority to GB0320300A priority Critical patent/GB0320300D0/en
Publication of GB0320300D0 publication Critical patent/GB0320300D0/en
Priority to NZ546044A priority patent/NZ546044A/en
Priority to CNB2004800247013A priority patent/CN100455586C/en
Priority to US10/569,287 priority patent/US7820658B2/en
Priority to AU2004268820A priority patent/AU2004268820B2/en
Priority to EA200600509A priority patent/EA009920B1/en
Priority to EP04768197.8A priority patent/EP1675861B1/en
Priority to PCT/GB2004/003641 priority patent/WO2005021552A1/en
Priority to KR1020067004012A priority patent/KR101139314B1/en
Priority to BRPI0413861-9A priority patent/BRPI0413861A/en
Priority to ES04768197.8T priority patent/ES2559779T3/en
Priority to CA2537135A priority patent/CA2537135C/en
Priority to JP2006524418A priority patent/JP4783731B2/en
Priority to ZA200601715A priority patent/ZA200601715B/en
Priority to NO20061416A priority patent/NO20061416L/en
Priority to HK07102556.5A priority patent/HK1095591A1/en
Priority to US12/690,983 priority patent/US8642594B2/en
Ceased legal-status Critical Current

Links

GB0320300A 2003-08-29 2003-08-29 Pyrimidothiophene compounds Ceased GB0320300D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0320300A GB0320300D0 (en) 2003-08-29 2003-08-29 Pyrimidothiophene compounds
JP2006524418A JP4783731B2 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compound
KR1020067004012A KR101139314B1 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
ES04768197.8T ES2559779T3 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
US10/569,287 US7820658B2 (en) 2003-08-29 2004-08-26 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors
AU2004268820A AU2004268820B2 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
EA200600509A EA009920B1 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
EP04768197.8A EP1675861B1 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
PCT/GB2004/003641 WO2005021552A1 (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
NZ546044A NZ546044A (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
BRPI0413861-9A BRPI0413861A (en) 2003-08-29 2004-08-26 pyrimidothiophene compounds
CNB2004800247013A CN100455586C (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
CA2537135A CA2537135C (en) 2003-08-29 2004-08-26 Pyrimidothiophene compounds
ZA200601715A ZA200601715B (en) 2003-08-29 2006-02-27 Pyrimidothiophene compounds
NO20061416A NO20061416L (en) 2003-08-29 2006-03-28 Pyrimidotiofenforbindelser
HK07102556.5A HK1095591A1 (en) 2003-08-29 2007-03-08 Pyrimidothiophene compounds
US12/690,983 US8642594B2 (en) 2003-08-29 2010-01-21 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0320300A GB0320300D0 (en) 2003-08-29 2003-08-29 Pyrimidothiophene compounds

Publications (1)

Publication Number Publication Date
GB0320300D0 true GB0320300D0 (en) 2003-10-01

Family

ID=28686587

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0320300A Ceased GB0320300D0 (en) 2003-08-29 2003-08-29 Pyrimidothiophene compounds

Country Status (3)

Country Link
CN (1) CN100455586C (en)
GB (1) GB0320300D0 (en)
ZA (1) ZA200601715B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
ATE540028T1 (en) * 2007-03-27 2012-01-15 Synta Pharmaceuticals Corp TRIAZINONE AND DIAZINONE DERIVATIVES SUITABLE AS HSP90 INHIBITORS
CA2698929C (en) 2007-09-14 2016-01-19 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
CA2697399C (en) 2007-09-14 2016-01-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
RS51660B (en) 2007-09-14 2011-10-31 Ortho-Mcneil-Janssen Pharmaceuticals Inc. 1`,3`-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1`h-[1,4`] bipyridinyl-2`-ones
JP5433582B2 (en) 2007-11-14 2014-03-05 ジャンセン ファーマシューティカルズ， インコーポレイテッド． Imidazo [1,2-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
WO2010025890A1 (en) 2008-09-02 2010-03-11 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
EP2346505B1 (en) 2008-10-16 2014-04-23 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
EP2430022B1 (en) 2009-05-12 2013-11-20 Janssen Pharmaceuticals, Inc. 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2430031B1 (en) 2009-05-12 2013-04-17 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
KR101147550B1 (en) * 2009-10-22 2012-05-17 한국과학기술연구원 2,7-Substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN103664991B (en) * 2012-09-19 2016-12-28 中国科学院福建物质结构研究所 Thiophene [2,3 d] pyrimidine derivatives, Its Preparation Method And Use
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
LT3431106T (en) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use
KR20220038826A (en) 2014-01-21 2022-03-29 얀센 파마슈티카 엔.브이. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
CN104230853B (en) * 2014-08-18 2016-04-13 湖南华腾制药有限公司 A kind of preparation method of (p-methylphenyl) methylamine-N-ethylmorpholine hydrochloride
AU2020232242A1 (en) * 2019-03-01 2021-09-09 Revolution Medicines, Inc. Bicyclic heteroaryl compounds and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
DE19632423A1 (en) * 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidines
EP2336133A1 (en) * 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity

Also Published As

Publication number Publication date
CN1842532A (en) 2006-10-04
CN100455586C (en) 2009-01-28
ZA200601715B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
GB0316915D0 (en) Compounds
GB0309781D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0320300D0 (en) Pyrimidothiophene compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0303523D0 (en) Compounds
GB0310851D0 (en) Compounds
GB0316865D0 (en) Compounds
GB0310890D0 (en) Glycopeptidic compounds
GB0314698D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)